A comprehensive view of American Society of Clinical Oncology (ASCO). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
AstraZeneca to highlight practice-changing cancer medicines in its pipeline at ASCO 2023; over 130 abstracts will feature 22 approved and potential new medicines
Published:
May 25, 2023
by AstraZeneca AB
|
Janssen to highlight scientific advances in cancer care at ASCO Annual Meeting and EHA 2023 Congress with more than 90 presentations showcasing portfolio and pipeline in hematologic malignancies and solid tumors
Published:
May 18, 2023
by U.S. Regulated Equity Markets (Alternative Disclosure) via PUBT
|
Merck to present extensive new research demonstrating significant progress in the treatment of certain earlier stage cancers and in advancing broad oncology pipeline at 2023 ASCO Annual Meeting
Published:
May 15, 2023
by Business Wire
|
Ask us about our Health Care Sector market view